Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02608385
Recruitment Status : Active, not recruiting
First Posted : November 18, 2015
Last Update Posted : March 15, 2022
Information provided by (Responsible Party):
University of Chicago

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 2020
Estimated Study Completion Date : July 2022